Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

H Lundbeck B (0ND5)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
32.60 -141.13    -81.24%
15:51:56 - Closed. Currency in DKK ( Disclaimer )
  • Volume: 35,022
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 32.58 - 33.32
Type:  Equity
Market:  United Kingdom
ISIN:  DK0010287234 
SEDOL:  BMY2ZQ6
H Lundbeck B 32.60 -141.13 -81.24%

H Lundbeck B Company Profile

 
Read the H Lundbeck B company profile to learn more about the business and the management team. View H Lundbeck B facts about employee data, company products and services, and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

5681

Equity Type

DRC

H. Lundbeck A/S, a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally. The company’s principal products include Abilify Maintena/Abilify Maintena for schizophrenia and bipolar I disorder in adults; Brintellix/Trintellix to treat depressive disorders; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Vyepti for migraine prevention; and Rexulti/Rxulti to treat MDD and schizophrenia. It also provides Azilect for treating Parkinson’s disease; Cipralex/Lexapro for depression; Ebixa to treat dementia; Onfi for epilepsy; Sabril for the treatment of refractory complex partial seizures and infantile spasms; Xenazine for chorea; Deanxit for depression; Cipramil for depression and anxiety; and Cisordinol to treat psychosis. The company sells its products primarily to distributors of pharmaceuticals, pharmacies, and hospitals. It has a partnership collaboration with Otsuka Pharmaceuticals Co., Ltd.; and collaboration with Alloy Therapeutics, Inc. for the discovery of novel biologics therapies. The company was founded in 1915 and is headquartered in Valby, Denmark.

Contact Information

Address Ottiliavej 9
Valby, 2500
Denmark
Phone 45 36 30 13 11
Fax 45 36 30 19 40

Top Executives

Name Age Since Title
Lars Soren Rasmussen 63 2013 Independent Chairman
Lars Erik Holmqvist 63 2015 Director
Lene Skole-Sorensen 63 2015 Deputy Chairman
Dorothea Wenzel 53 2021 Independent Director
Hossein Armandi 62 2022 Employee Representative Director
Santiago Arroyo 64 2021 Independent Director
Jakob Riis 58 2023 Director
Dorte Clausen 40 2022 Employee Representative Director
Lasse Skibsbye 41 2022 Employee Representative Director
Jeffrey Berkowitz 58 2018 Independent Director
Camilla Gram Andersson 52 2022 Employee Representative Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

HLUNb Price Commentary

Write your thoughts about H Lundbeck L
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Md Rasel Ahmed
Md Rasel Ahmed Jan 06, 2023 11:52
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I think this company growths to 80.50 in three or four month..
rakesh verma
rakesh verma Dec 19, 2022 7:04
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I think company growths to 76.59 in two or three months
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email